SEC Form 4 · accession 0000899243-18-016209
Arcus Biosciences, Inc. · RCUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Jarrett
Officer — See Remarks
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724521
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.95 | Jun 8, 2018 | A | 161,114 | A | — | Jun 7, 2028 | Common Stock | 161,114 | 161,114 | D |
Explanation of responses
- F11/48th of the shares of common stock subject to the option vest on the last day of the calendar month after May 31, 2018, and 1/48th of the shares subject to the option vest on the last day of the 47 calendar months immediately thereafter, subject to the Reporting Person's continued service to the Company.
Remarks
Chief Operating Officer and Chief Financial Officer